Literature DB >> 22527897

Triploid and diploid embryonic stem cell lines derived from tripronuclear human zygotes.

Xinjie Chen1, Yumei Luo, Yong Fan, Lei Yue, Xueshi Wu, Yaoyong Chen, Xiaofang Sun.   

Abstract

PURPOSE: Human embryonic stem cells (hESCs) are self-renewing, pluripotent cells that are valuable research tools and hold promise for use in regenerative medicine. The need for new hESC lines motivated our attempts to find a new resource for the derivation of hESC lines. The aim of this work was to establish more hESC lines from abnormal fertilized zygotes and to meet the emerging requirements for their use in cell replacement therapies, disease modeling, and basic research.
METHODS: A total of 130 tripronuclear human zygotes was collected 18-20 h post-insemination and cultured in a modified culture medium. The inner cell mass of 12 blastocysts were isolated by a mechanical method in order to establish embryonic stem cell lines.
RESULTS: We established four hESC lines derived from 130 trinuclear zygotes, one of which was triploid and the others were diploid. The efficiency of deriving hESC lines is 3.08 %. The ratio of deriving triploid and diploid hESC lines is 1:3. All of these hESC lines exhibited similar markers of undifferentiated hESCs and had the typical morphology of hESCs, a capacity for long-term proliferation, and pluripotent differentiation potential both in vivo and in vitro.
CONCLUSIONS: These abnormal zygotes, which otherwise would have been discarded, can serve as an alternative source for normal euploid hESC lines.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22527897      PMCID: PMC3430782          DOI: 10.1007/s10815-012-9764-4

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  29 in total

1.  Development of the human dispermic embryo.

Authors:  A H Sathananthan; J J Tarin; L Gianaroli; S C Ng; V Dharmawardena; M C Magli; R Fernando; A O Trounson
Journal:  Hum Reprod Update       Date:  1999 Sep-Oct       Impact factor: 15.610

2.  Derivation of embryonic stem-cell lines from human blastocysts.

Authors:  Chad A Cowan; Irina Klimanskaya; Jill McMahon; Jocelyn Atienza; Jeannine Witmyer; Jacob P Zucker; Shunping Wang; Cynthia C Morton; Andrew P McMahon; Doug Powers; Douglas A Melton
Journal:  N Engl J Med       Date:  2004-03-03       Impact factor: 91.245

3.  The cumulative embryo score: a predictive embryo scoring technique to select the optimal number of embryos to transfer in an in-vitro fertilization and embryo transfer programme.

Authors:  C V Steer; C L Mills; S L Tan; S Campbell; R G Edwards
Journal:  Hum Reprod       Date:  1992-01       Impact factor: 6.918

4.  The science and ethics of induced pluripotency: what will become of embryonic stem cells?

Authors:  David G Zacharias; Timothy J Nelson; Paul S Mueller; C Christopher Hook
Journal:  Mayo Clin Proc       Date:  2011-07       Impact factor: 7.616

5.  The chromosomal constitution of multipronuclear zygotes resulting from in-vitro fertilization.

Authors:  B Rosenbusch; M Schneider; K Sterzik
Journal:  Hum Reprod       Date:  1997-10       Impact factor: 6.918

6.  Tripronuclear human oocytes: altered cleavage patterns and subsequent karyotypic analysis of embryos.

Authors:  I Kola; A Trounson; G Dawson; P Rogers
Journal:  Biol Reprod       Date:  1987-09       Impact factor: 4.285

7.  Culture and transfer of viable blastocysts: a feasible proposition for human IVF.

Authors:  D K Gardner; M Lane; W B Schoolcraft
Journal:  Hum Reprod       Date:  2000-12       Impact factor: 6.918

8.  Improved isolation and culture of embryonic stem cells from Chinese miniature pig.

Authors:  Ming Li; Wei Ma; Yi Hou; Xiao-Fang Sun; Qing-Yuan Sun; Wei-Hua Wang
Journal:  J Reprod Dev       Date:  2004-04       Impact factor: 2.214

9.  Factors affecting the incidence of polyploidy in a human in vitro fertilization program.

Authors:  P C Ho; W S Yeung; Y F Chan; W W So; S T Chan
Journal:  Int J Fertil Menopausal Stud       Date:  1994 Jan-Feb

10.  Derivation of a diploid human embryonic stem cell line from a mononuclear zygote.

Authors:  Edith Suss-Toby; S Gerecht-Nir; M Amit; D Manor; J Itskovitz-Eldor
Journal:  Hum Reprod       Date:  2004-01-29       Impact factor: 6.918

View more
  6 in total

1.  Derivation of human triploid trophoblast stem cells.

Authors:  Xuhui Kong; Xin Chen; Songbang Ou; Wenjun Wang; Ruiqi Li
Journal:  J Assist Reprod Genet       Date:  2022-05       Impact factor: 3.357

2.  Diploid, but not haploid, human embryonic stem cells can be derived from microsurgically repaired tripronuclear human zygotes.

Authors:  Yong Fan; Rong Li; Jin Huang; Yang Yu; Jie Qiao
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

3.  Improved efficiency of microsurgical enucleated tripronuclear zygotes development and embryonic stem cell derivation by supplementing epidermal growth factor, brain-derived neurotrophic factor, and insulin-like growth factor-1.

Authors:  Yong Fan; Rong Li; Jin Huang; Hong-Cui Zhao; Ting Ding; Xiaofang Sun; Yang Yu; Jie Qiao
Journal:  Stem Cells Dev       Date:  2014-01-24       Impact factor: 3.272

4.  The parental origin correlates with the karyotype of human embryos developing from tripronuclear zygotes.

Authors:  Mette Warming Joergensen; Rodrigo Labouriau; Johnny Hindkjaer; Magnus Stougaard; Steen Kolevraa; Lars Bolund; Inge Errebo Agerholm; Lone Sunde
Journal:  Clin Exp Reprod Med       Date:  2015-03-31

5.  Triploid human embryonic stem cells derived from tripronuclear zygotes displayed pluripotency and trophoblast differentiation ability similar to the diploid human embryonic stem cells.

Authors:  Ruttachuk Rungsiwiwut; Pranee Numchaisrika; Vichuda Ahnonkitpanit; Pramuan Virutamasen; Kamthorn Pruksananonda
Journal:  J Reprod Dev       Date:  2016-01-28       Impact factor: 2.214

6.  Developmental potential of clinically discarded human embryos and associated chromosomal analysis.

Authors:  Guidong Yao; Jiawei Xu; Zhimin Xin; Wenbin Niu; Senlin Shi; Haixia Jin; Wenyan Song; Enyin Wang; Qingling Yang; Lei Chen; Yingpu Sun
Journal:  Sci Rep       Date:  2016-04-05       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.